John L. Cassis Joins Nutrition 21 Board Of Directors

John L. Cassis Joins Nutrition 21 Board Of Directors Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack.
Home Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Modern Science Confirms Ancient Wisdom! Modern Science Confirms Ancient Wisdom! "Natural" or "Plant-Derived" Labeling Can Mislead CDN: Natural Health Products Report - Update NPI Editorial: Are we using Best Practices? AHPA Update: Kava Information from the AHPA Executive Committee European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing Statement on Kava in New Zealand BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning Weider Announces Fiscal 2005 Third Quarter Results Company reports net sales of $65.6 million for Q3, compared to $67.5 million prior year, net income was $1.2 million, or $0.05 per share, compared to $2.6 million, or $0.10 per share the previous year. The company attributes decrease in sales to domestic private label sales and weakness in its Haleko business unit's Multipower and Multaben brands. In other news, the company announced the sale of assets of its Active Nutrition Unit to Weider Global Nutrition for $14.0 million. Weider Announces Fiscal 2005 Third Quarter Results Company reports net sales of $65.6 million for Q3, compared to $67.5 million prior year, net income was $1.2 million, or $0.05 per share, compared to $2.6 million, or $0.10 per share the previous year. The company attributes decrease in sales to domestic private label sales and weakness in its Haleko business unit's Multipower and Multaben brands. In other news, the company announced the sale of assets of its Active Nutrition Unit to Weider Global Nutrition for $14.0 million. Phillips Health, LLC Announces Company Name Change to Healthy Directions, LLC Name change to Healthy Directions, LLC, effective immediately. Phillips Health, LLC Announces Company Name Change to Healthy Directions, LLC Name change to Healthy Directions, LLC, effective immediately. Great Spirit Ventures Acquires The Natural Dentist (R) Great Spirit Ventures, LLC has acquired The Natural Dentist(R), adding company to its portfolio of companies addressing health and wellness. Great Spirit Ventures Acquires The Natural Dentist (R) Great Spirit Ventures, LLC has acquired The Natural Dentist(R), adding company to its portfolio of companies addressing health and wellness. NutraCea(R) Executes Definitive Agreement to Merge with RiceX Companies sign definitive agreement to merge with a newly formed subsidiary of NutraCea merging into RiceX, RiceX becoming a wholly owned subsidiary of NutraCea, and the shareholders of RiceX to receive shares of NutraCea common stock in exchange for RiceX shares. NutraCea(R) Executes Definitive Agreement to Merge with RiceX Companies sign definitive agreement to merge with a newly formed subsidiary of NutraCea merging into RiceX, RiceX becoming a wholly owned subsidiary of NutraCea, and the shareholders of RiceX to receive shares of NutraCea common stock in exchange for RiceX shares. Whole Living Reports 2004 Year End Results Company reports revenues for 2004 of $6,758,535 with a net loss of ($0.06) per share. Whole Living Reports 2004 Year End Results Company reports revenues for 2004 of $6,758,535 with a net loss of ($0.06) per share. Neptune Technologies & Bioressources Inc. Reports Q3 Results Company reports revenues of $1,292,460 compared to $601,576 prior year, with an EBITDA of $117,000 compared to a negative EBITDA of $240,000 in 2004. Neptune Technologies & Bioressources Inc. Reports Q3 Results Company reports revenues of $1,292,460 compared to $601,576 prior year, with an EBITDA of $117,000 compared to a negative EBITDA of $240,000 in 2004. Chr. Hansen opens new office in Colombia New premises is to be the cornerstone in the company’s aim to gain new market shares. Chr. Hansen opens new office in Colombia New premises is to be the cornerstone in the company’s aim to gain new market shares. Chr. Hansen opens new office in Colombia New premises is to be the cornerstone in the company’s aim to gain new market shares. Chr. Hansen opens new office in Colombia New premises is to be the cornerstone in the company’s aim to gain new market shares. Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role. Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role. Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role. Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role. Technology Flavors & Fragrances, Inc. Enters into Definitive Merger Agreement Company merging with FFG Industries, Inc. Technology Flavors & Fragrances, Inc. Enters into Definitive Merger Agreement Company merging with FFG Industries, Inc. Cargill and Diversa Sign Collaboration for Development of Novel Enzymes Companies to collaborate to discover and develop novel enzymes for the cost- effective production of a proprietary product. Cargill and Diversa Sign Collaboration for Development of Novel Enzymes Companies to collaborate to discover and develop novel enzymes for the cost- effective production of a proprietary product. Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. Fonterra Ends National Foods Offer and Divests Stake Fonterra announces it intends to withdraw onw offer and accept San Miguel Corporation’s offer of $6.40 per share, if that offer is unconditional. Fonterra Ends National Foods Offer and Divests Stake Fonterra announces it intends to withdraw onw offer and accept San Miguel Corporation’s offer of $6.40 per share, if that offer is unconditional. New Morning Corporation Appoints New Management and Director Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director. New Morning Corporation Appoints New Management and Director Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director. New Morning Corporation Appoints New Management and Director Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director. New Morning Corporation Appoints New Management and Director Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director. VitaCube Completes Financing Company has closed its offer of 1,500,000 units at $6.15 per unit for gross proceeds of $9,225,000,led by The Shemano Group, S.W. Bach & Company and Neidiger Tucker Bruner, Inc. VitaCube Completes Financing Company has closed its offer of 1,500,000 units at $6.15 per unit for gross proceeds of $9,225,000,led by The Shemano Group, S.W. Bach & Company and Neidiger Tucker Bruner, Inc. Renaissance-Glykon HCA Agreement in Force Company has confirmed that exclusive licensing agreement with Glykon Technologies Group, LLC is in full force. Renaissance-Glykon HCA Agreement in Force Company has confirmed that exclusive licensing agreement with Glykon Technologies Group, LLC is in full force. Phosphagenics Ltd and Swisse Vitamins Pty Ltd reach agreement for Vitamin E phosphate Company signs deal to supply Vitamin E phosphate to Australian company Swisse Vitamins Pty Ltd. Phosphagenics Ltd and Swisse Vitamins Pty Ltd reach agreement for Vitamin E phosphate Company signs deal to supply Vitamin E phosphate to Australian company Swisse Vitamins Pty Ltd. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division. Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division. Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division. Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division. CAROTECH BHD - Enroute to IPO on the Malaysian MESDAQ Company announces its initial public offering of 76,690,000 shares RM0.40 each. The listing is expected to raise RM30.7 million that will be used to repay borrowings and for working capital. CAROTECH BHD - Enroute to IPO on the Malaysian MESDAQ Company announces its initial public offering of 76,690,000 shares RM0.40 each. The listing is expected to raise RM30.7 million that will be used to repay borrowings and for working capital. CoolBrands reports operating results for second quarter of fiscal 2005 Company reports revenues in the quarter were $87,549,000, down 17.0% from the prior year, with a net loss of ($3,973,000), ($0.07 per basic and diluted share), compared with net earnings of $9,475,000 ($0.17 per basic and diluted share) prior year. CoolBrands reports operating results for second quarter of fiscal 2005 Company reports revenues in the quarter were $87,549,000, down 17.0% from the prior year, with a net loss of ($3,973,000), ($0.07 per basic and diluted share), compared with net earnings of $9,475,000 ($0.17 per basic and diluted share) prior year. PacificHealth Laboratories, Inc. Reports Year End and Fourth Quarter 2004 Results Company reports 2004 revenues of $6,807,271, compared to $5,453,571 prior year, reporting a net loss of ($2,521,096), or ($0.25) per share for the year compared to a net loss of ($1,451,274), or ($0.20) per share for 2003. PacificHealth Laboratories, Inc. Reports Year End and Fourth Quarter 2004 Results Company reports 2004 revenues of $6,807,271, compared to $5,453,571 prior year, reporting a net loss of ($2,521,096), or ($0.25) per share for the year compared to a net loss of ($1,451,274), or ($0.20) per share for 2003. NutraCea Enters Into Strategic Relationship With W. F. Young, Inc. Company's largest customer, W. F. Young, Inc., has made a strategic investment in NutraCea which will result in NutraCea obtaining the exclusive manufacturing rights for existing and new Stabilized Rice Bran Products. NutraCea Enters Into Strategic Relationship With W. F. Young, Inc. Company's largest customer, W. F. Young, Inc., has made a strategic investment in NutraCea which will result in NutraCea obtaining the exclusive manufacturing rights for existing and new Stabilized Rice Bran Products. Herbalife Appoints Luigi Gratton, M.D., M.P.H, Vice President, Medical Affairs and Education Company appoints Luigi Gratton, M.D., M.P.H., as vice president, medical affairs and education effective July 5, 2005. Herbalife Appoints Luigi Gratton, M.D., M.P.H, Vice President, Medical Affairs and Education Company appoints Luigi Gratton, M.D., M.P.H., as vice president, medical affairs and education effective July 5, 2005. Herbalife Appoints Luigi Gratton, M.D., M.P.H, Vice President, Medical Affairs and Education Company appoints Luigi Gratton, M.D., M.P.H., as vice president, medical affairs and education effective July 5, 2005. Herbalife Appoints Luigi Gratton, M.D., M.P.H, Vice President, Medical Affairs and Education Company appoints Luigi Gratton, M.D., M.P.H., as vice president, medical affairs and education effective July 5, 2005. OraLabs Announces Earnings for 2004 Company reports revenues of $13,130,579 with a loss of ($.12) per share, or ($565,108), compared to 2003 reported revenues of $14,068,220 with earnings of $.00 per share, or $1,222. OraLabs Announces Earnings for 2004 Company reports revenues of $13,130,579 with a loss of ($.12) per share, or ($565,108), compared to 2003 reported revenues of $14,068,220 with earnings of $.00 per share, or $1,222. Tate & Lyle Expands Value Added Ingredients Portfolio with the Signing of North American Licensing Agreement with Alleggra Foods Limited Under the agreement Tate & Lyle has the rights to manufacture, distribute and market Alleggra(TM)(full function, egg product that is soy-based) in North America, including the U.S., Canada and Mexico. Tate & Lyle Expands Value Added Ingredients Portfolio with the Signing of North American Licensing Agreement with Alleggra Foods Limited Under the agreement Tate & Lyle has the rights to manufacture, distribute and market Alleggra(TM)(full function, egg product that is soy-based) in North America, including the U.S., Canada and Mexico. NSF-ISR Establishes Presence in Canada NSF International Strategic Registrations, Ltd. acquires operations of Deloitte & Touche Quality Registrar Inc. NSF-ISR Establishes Presence in Canada NSF International Strategic Registrations, Ltd. acquires operations of Deloitte & Touche Quality Registrar Inc. NSF-ISR Establishes Presence in Canada NSF International Strategic Registrations, Ltd. acquires operations of Deloitte & Touche Quality Registrar Inc. NSF-ISR Establishes Presence in Canada NSF International Strategic Registrations, Ltd. acquires operations of Deloitte & Touche Quality Registrar Inc. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. Peer-Reviewed Published Study Demonstrates Safety of UC-II® A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe. BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel. ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). ISO14001 certification granted to Indena Indena has been granted the ISO14001 certification for its main production site of Settala (Milan). New Company for “Change-The-World” Entrepreneurs™ Launches GMP Labs Expands Liquid Nutraceutical Capabilities What Parents Should Know About Kids and Supplements What Parents Should Know About Kids and Supplements Oats Beat Back Cholesterol Oats Beat Back Cholesterol Seniors: Pump Up for Strong Bones and Heart Seniors: Pump Up for Strong Bones and Heart	PURCHASE, N.Y., Apr 11, 2005 (BUSINESS WIRE) -- Nutrition 21, Inc. (NXXI), the leading developer and marketer of chromium-based nutritional supplements, today announced that John L. Cassis has joined the Company's Board of Directors. He succeeds Robert Pollack, who has stepped down as a director after many years of exemplary service. Mr. Cassis is a founding partner of Cross Atlantic Partners, Inc., a private equity firm that invested $3 million in the company's recently announced financing. John Gutfreund, Senior Advisor of C.E. Unterberg, Towbin and Chairman of the Nutrition 21 board, commented, "It is a pleasure to welcome John Cassis to Nutrition 21's Board of Directors. He has over 30 years of hands-on experience helping emerging organizations reach their potential. His guidance in strategic planning and deep business relationships in the healthcare industry will be assets to Nutrition 21. We look forward to his involvement as we focus on building greater value for our shareholders." Cassis commented, "Nutrition 21 is uniquely positioned to participate in an emerging nutrition market with significant growth potential based on sound scientific data and patents surrounding its chromium formulations." Cross Atlantic Partners is a private equity firm that invests in later-stage life science, medical, and nutraceutical companies. Before founding Cross Atlantic, Mr. Cassis headed Salomon Brothers Venture Capital and founded the J&J Development Corporation, Johnson & Johnson's venture capital arm. He is a director of Medivance Inc., Galt Associates Inc., Eximias Pharmaceutical Corp., and Medco Health Solutions. Mr. Cassis received his Bachelor of Arts from Harvard University and his MBA from the Harvard Business School. About Nutrition 21, Inc. Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax(R) chromium picolinate, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome(R), which is available through diabetes educators or at www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses. More information is available at www.nutrition21.com. Safe Harbor Provision This press release may contain certain forward-looking statements. The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. These forward-looking statements are based largely on the Company's current expectations and are subject to a number of risks and uncertainties, including without limitation: the effect of the expiration of patents; regulatory issues; uncertainty in the outcomes of clinical trials; changes in external market factors; changes in the Company's business or growth strategy or an inability to execute its strategy due to changes in its industry or the economy generally; the emergence of new or growing competitors; various other competitive factors; and other risks and uncertainties indicated from time to time in the Company's filings with the Securities and Exchange Commission, including its Form 10-K for the year ended June 30, 2004. Actual results could differ materially from the results referred to in the forward-looking statements. In light of these risks and uncertainties, there can be no assurance that the results referred to in the forward-looking statements contained in this press release will in fact occur. Additionally, the Company makes no commitment to disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that may bear upon forward-looking statements.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software